Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
What are hidradenitis suppurativa (HS) clinical trials?
HS clinical trials are research studies that test new and existing treatment options for hidradenitis suppurativa, from medications to other approaches, under close medical supervision. They help researchers learn what actually works, since only three medicines are currently FDA approved for HS. Joining a study is one way to access newer treatment options while they are still being studied, and every trial walks you through eligibility and informed consent before you agree to anything.
Interested in learning more about HS treatment? Read our guide: HS Treatment Options: Approved Medicines & Clinical Trials
Types of clinical trials for hidradenitis suppurativa
Clinical trials for Hidradenitis Suppurativa (HS) encompass a wide array of studies, each with a distinct focus aimed at not only enhancing our understanding and treatment of the condition but also exploring various approaches to improve patient care. These include investigating treatments, developing better diagnostic methods, identifying effective prevention strategies, and efforts to enhance the quality of life for those affected.
Treatment trials
Treatment trials focus on testing medications or finding ways to use existing treatments for HS. This includes testing drugs that target specific inflammatory processes, using antibiotics to reduce infection risks, or evaluating surgical options to remove damaged tissue. The goal is to find more effective treatments with fewer side effects, potentially including drugs already on the market but not previously used for HS. These trials aim to improve treatment options for HS patients by identifying what works best.
Diagnostic studies
Diagnostic studies aim to improve how HS is diagnosed, making it quicker and more accurate. This involves using genetic testing, advanced imaging techniques, and other non-invasive methods to identify the disease earlier. The goal is to reduce the time it takes to diagnose HS, allowing for earlier treatment. By finding reliable markers of the disease, these studies help in tailoring the diagnosis to each patient's condition, potentially leading to better management strategies.
Prevention trials
Prevention trials look for ways to prevent HS from developing, especially in people at higher risk. These studies may explore how lifestyle changes, like diet adjustments or quitting smoking, could reduce the risk of developing HS. They also test whether certain medications can prevent HS symptoms in people who are genetically predisposed but have not yet shown symptoms. The aim is to find strategies that can stop the disease before it starts, focusing on early intervention and risk reduction.
Quality of life studies
Quality of life (QoL) studies investigate how to improve the daily lives of people with HS. This includes testing interventions for pain relief, reducing the appearance of scars, and addressing the psychological impacts of HS, such as anxiety and depression. These studies also examine the benefits of patient education, psychological support, and lifestyle counseling in helping patients manage their condition better. The goal is to develop a holistic care approach that not only treats the physical symptoms of HS but also supports the patient's mental and emotional well-being, improving their overall quality of life.
Interested in learning more about hidradenitis suppurativa (HS)? Read all about what HS is, what can cause it, how it's diagnosed, and more in our comprehensive guide!
Who can participate in HS clinical trials?
Individuals interested in participating in Hidradenitis Suppurativa (HS) clinical trials must meet certain criteria to ensure both their safety and the integrity of the trial results. Generally, eligibility is based on having a confirmed diagnosis of HS. Most trials require participants to be of a certain age, typically 18 years or older, although some studies may include younger participants with parental consent.
Eligibility criteria may also consider the severity of the condition, overall health status, treatment history, and specific lifestyle factors. Participants must be able to give informed consent and comply with trial procedures.
What to expect in a clinical trial for hidradenitis suppurativa?
Before joining a clinical trial for hidradenitis suppurativa (HS), participants undergo a screening to confirm their eligibility and are informed in detail about the trial's purpose, procedures, and potential risks and benefits. This ensures they make an informed decision to participate. Once enrolled, they receive baseline assessments before starting treatments, which may vary from drugs to lifestyle interventions. Throughout the trial, their health and response to treatment are closely monitored, sometimes requiring them to keep a symptom diary.
After the treatment phase, participants undergo final evaluations to measure the effectiveness of the intervention, with some studies also conducting long-term follow-ups. Participation demands a significant time commitment and may involve frequent site visits. It's crucial to understand the costs covered by the trial and the balance between potential benefits and risks.
Do HS trial participants get paid?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost. Details always come in the informed consent process before you agree to anything.
How to enroll in a clinical trial for hidradenitis suppurativa
Enrolling in a clinical trial for hidradenitis suppurativa through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to your requirements.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get Started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.